Collaborators 


 

 

Accelrys

Accelrys Integrates ACD/pKa Batch
with WebLab MedChem Explorer

MSI SAN DIEGO, CA, October 19, 1999 - Molecular Simulations Inc. (MSI)*, a subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP), announces that MSI's WebLab® MedChem Explorer™ now integrates with a leading physical property prediction module for pKa prediction from Advanced Chemistry Development (the pKa Module of ACD/PhysChem Batch).

"The expanding toolset of physical property algorithms available from Advanced Chemistry Development can offer the combinatorial chemistry application specialist valuable new capabilities for screening libraries," says Antony Williams, Chief Science Officer at ACD/Labs. "Now the integration to WebLab MedChem Explorer offers additional Web-based accessibility," says Dr. Williams.

WebLab MedChem Explorer is a Web-enabled application for medicinal chemists that provides data access, property prediction, and other functions to improve communication, collaboration, productivity, and creativity. "With the interface between ACD/Labs' pKa prediction tool and MSI's MedChem Explorer, experimental chemists working in drug discovery and design can use this information to make decisions in prioritizing their lead compounds or libraries," says Osman Güner, Senior Product Manager for Rational and Combinatorial Drug Design at MSI.

Molecular Simulations Inc. (http://www.msi.com), a subsidiary of Pharmacopeia, Inc. (http://www.pcop.com), is a leading provider of molecular modeling, simulation, and informatics software to the world's foremost research and development facilities. Using MSI's innovative products, researchers can organize and analyze scientific data, share biological and chemical information, and develop novel compounds, materials, and processes. Founded in 1984, the company employs over 325 people, nearly half of whom are Ph.D. scientists. Company headquarters are in San Diego, California. European headquarters are in Cambridge, England. MSI maintains sales and support facilities in Munich, Germany; Paris, France; and Tokyo, Japan.

Standard disclaimer applies.


ACD/pKa Batch acts as the "back end engine" for the MSI product
"C2·Descriptor+" C2·QSAR+, C2·GA, and C2·Descriptor+ are integrated parts of the QSAR analysis package within the Cerius2 user interface.

Find out more about the C2·Descriptor+ module here

Find out more about ACD/pKa Batch here.

 


*Molecular Simulations Inc. (MSI) was renamed Accelrys Inc. on June 1, 2001.

TOP

This page was last updated 05 June 2006
 

  Products | Solutions | Support
Online Services | Resources
About Us | Downloads | Events
Site Map | Contact Us
 

 
Copyright © 1996 - 2008 Advanced Chemistry Development     All rights reserved